Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

515 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myeloid-derived suppressor cells (MDSCs) depletion by cabozantinib improves the efficacy of anti-HER2 antibody-based immunotherapy in a 4T1-HER2 murine breast cancer model.
Khaki Bakhtiarvand V, Ramezani-Ali Akbari K, Amir Jalali S, Hojjat-Farsangi M, Jeddi-Tehrani M, Shokri F, Shabani M. Khaki Bakhtiarvand V, et al. Among authors: shabani m. Int Immunopharmacol. 2022 Dec;113(Pt B):109470. doi: 10.1016/j.intimp.2022.109470. Epub 2022 Nov 23. Int Immunopharmacol. 2022. PMID: 36435059
Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b+/Gr-1+ myeloid cells depletion using a recombinant peptibody in 4 T1-HER2 tumor model.
Ramezani-Aliakbari K, Khaki-Bakhtiarvand V, Mahmoudian J, Asgarian-Omran H, Shokri F, Hojjat-Farsangi M, Jeddi-Tehrani M, Shabani M. Ramezani-Aliakbari K, et al. Among authors: shabani m. Int Immunopharmacol. 2023 Aug;121:110463. doi: 10.1016/j.intimp.2023.110463. Epub 2023 Jun 14. Int Immunopharmacol. 2023. PMID: 37327513
Co-delivery of insulin-like growth factor 1 receptor specific siRNA and doxorubicin using chitosan-based nanoparticles enhanced anticancer efficacy in A549 lung cancer cell line.
Shali H, Shabani M, Pourgholi F, Hajivalili M, Aghebati-Maleki L, Jadidi-Niaragh F, Baradaran B, Movassaghpour Akbari AA, Younesi V, Yousefi M. Shali H, et al. Among authors: shabani m. Artif Cells Nanomed Biotechnol. 2018 Mar;46(2):293-302. doi: 10.1080/21691401.2017.1307212. Epub 2017 Mar 31. Artif Cells Nanomed Biotechnol. 2018. PMID: 28362176
Cloning, expression and characterization of a peptibody to deplete myeloid derived suppressor cells in a murine mammary carcinoma model.
Ramezani-Ali Akbari K, Khaki-Bakhtiarvand V, Mahmoudian J, Asgarian-Omran H, Shokri F, Hojjat-Farsangi M, Jeddi-Tehrani M, Shabani M. Ramezani-Ali Akbari K, et al. Among authors: shabani m. Protein Expr Purif. 2022 Dec;200:106153. doi: 10.1016/j.pep.2022.106153. Epub 2022 Aug 19. Protein Expr Purif. 2022. PMID: 35995320
515 results